Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
roberta.lattanzi@uniroma1.it
Roberta Lattanzi
Professore Associato
Struttura:
DIPARTIMENTO DI FISIOLOGIA E FARMACOLOGIA "VITTORIO ERSPAMER"
E-mail:
roberta.lattanzi@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
CURRENT ISSUES IN MOLECULAR BIOLOGY
2022
The Role of Prokineticin 2 in Oxidative Stress and in Neuropathological Processes
FRONTIERS IN PHARMACOLOGY
2021
A Palmitoylethanolamide Producing Lactobacillus paracasei Improves Clostridium difficile Toxin A-Induced Colitis
FRONTIERS IN PHARMACOLOGY
2021
High-fat diet impairs duodenal barrier function and elicits glia-dependent changes along the gut-brain axis that are required for anxiogenic and depressive-like behaviors
JOURNAL OF NEUROINFLAMMATION
2021
Role of Enteric Glia as Bridging Element between Gut Inflammation and Visceral Pain Consolidation during Acute Colitis in Rats
BIOMEDICINES
2021
The balance of concentration between Prokineticin 2β and Prokineticin 2 modulates the food intake by STAT3 signaling
BBA ADVANCES
2021
Versatile role of prokineticins and prokineticin receptors in neuroinflammation
BIOMEDICINES
2021
Analysis of role of aromatic residues in extracellular loop 2 of Prokineticin receptor 2 in ligand binding probed with genetically encoded photo-crosslinkers
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
2021
Trypanosoma cruzi trans-sialidase induces STAT3 and ERK activation by prokineticin receptor 2 binding
CELL BIOCHEMISTRY AND FUNCTION
2021
Increase of Prokineticin-2 in Serum of Patients with Parkinson's Disease
MOVEMENT DISORDERS
2021
Abnormal Pain Sensation in Mice Lacking the Prokineticin Receptor PKR2: Interaction of PKR2 with Transient Receptor Potential TRPV1 and TRPA1
NEUROSCIENCE
2020
Prokineticin Receptor Inhibition With PC1 Protects Mouse Primary Sensory Neurons From Neurotoxic Effects of Chemotherapeutic Drugsin vitro
FRONTIERS IN IMMUNOLOGY
2020
Identification and characterization of prokineticin receptor 2 splicing variant and its modulation in an animal model of alzheimer's disease
NEUROPEPTIDES
2019
Chemokines in alzheimer’s disease: new insights into prokineticins, chemokine-like proteins
FRONTIERS IN PHARMACOLOGY
2019
Targeting prokineticin system counteracts hypersensitivity, neuroinflammation, and tissue damage in a mouse model of bortezomib-induced peripheral neuropathy
JOURNAL OF NEUROINFLAMMATION
2019
The prokineticin receptor antagonist PC1 rescues memory impairment induced by β amyloid administration through the modulation of prokineticin system
NEUROPHARMACOLOGY
2019
Involvement of the chemokine prokineticin-2 (PROK2) in Alzheimer's disease: from animal models to the human pathology
CELLS
2019
HIV-1 Tat-induced diarrhea is improved by the PPAR alpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
JOURNAL OF NEUROINFLAMMATION
2018
PK2β ligand, a splice variant of prokineticin 2, is able to modulate and drive signaling through PKR1 receptor
NEUROPEPTIDES
2018
The multimodal antidepressant vortioxetine causes analgesia in a mouse model of chronic neuropathic pain
MOLECULAR PAIN
2018
« prima
< precedente
1
2
3
seguente ›
ultima »
Progetti di Ricerca
The prokineticin system: a possible new therapeutic target for the pharmacological treatment of depression
Role of PK2/PKRs in chronic pain induction and maintenance: new pharmacological targets to control pain and neuroinflammation
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma